Deprecated Macroscopic tumor configuration by CAP cancer protocols 33727-9
LOINC Code
LOINC code | 33727-9 | ||
---|---|---|---|
name | Deprecated Macroscopic tumor configuration by CAP cancer protocols | ||
status | DEPRECATED | ||
status reason | Duplicate - Macroscopic tumor configuration is typically reported based on a list of possible results and not as paragraphs of text; therefore, this term was deprecated and mapped to its Nominal counterpart. | ||
Replacements | alternatives to this code:
| ||
Fully-Specified Name | |||
component | Macroscopic tumor configuration | ||
property | Find = Finding | ||
time | Pt = Point in time: To identify measures at a point in time. This is a synonym for “spot” or “random” as applied to urine measurements. | ||
system | Specimen | ||
scale | Nar = Narrative: Text narrative, such as the description of a microscopic part of a surgical papule test. | ||
method | CAP cancer protocols | ||
Additional Names | |||
short name | Deprecated Macro tumor config CAP prot | ||
Basic Attributes | |||
class | PATH.PROTOCOLS.GENER | ||
type | 1 Laboratory | ||
order vs. observation | Observation | ||
Associated Observations | |||
LOINC codes that represent optional associated observation(s) for a clinical observation or laboratory test. A LOINC term may represent a single associated observation or panel containing several associated observations. | |||
History/Usage | |||
first released | |||
last updated | 2.61 | ||
last change type | DEL - delete (deprecate) | ||
change reason | Removed Method of "CAP cancer protocol" and copyright because this is not a CAP-specific concept | ||
Related Names | |||
|
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © 1995-2024, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.
Thank you for choosing Find-A-Code, please Sign In to remove ads.